Trinity Biotech plc (TRIB) Tops Q3 EPS by 2c, Revenues Rose 6% Y/Y
Tweet
Share
E-mailGet Alerts TRIB Hot Sheet
Join SI Premium – FREE
Trinity Biotech plc (NASDAQ: TRIB) reported Q3 EPS of $0.18, $0.02 better than the analyst estimate of $0.16. Revenue for the quarter came in at $19.8 million versus the consensus estimate of $19.76 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trinity Biotech secures $7M from Perceptive, regains Nasdaq compliance
- Trinity Biotech Secures Additional $7.0 Million Investment from Perceptive Advisors and Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
